Swiss National Bank Forma Therapeutics Holdings, Inc. Transaction History

Swiss National Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$5.1 - $10.0 $198,900 - $390,000	39,000 Added 99.24%	78,300 $539,000
Q1 2022 May 09, 2022	BUY	$8.34 - $14.69 $22,518 - $39,663	2,700 Added 7.38%	39,300 $365,000
Q3 2021 Nov 08, 2021	BUY	$21.22 - $25.7 $44,562 - $53,970	2,100 Added 6.09%	36,600 $849,000
Q2 2021 Aug 06, 2021	SELL	$22.86 - $30.95 $16,002 - $21,665	-700 Reduced 1.99%	34,500 $859,000
Q1 2021 May 07, 2021	SELL	$24.58 - $42.82 $49,160 - $85,640	-2,000 Reduced 5.38%	35,200 $986,000
Q4 2020 Feb 05, 2021	BUY	$34.9 - $51.08 $1.3 Million - $1.9 Million	37,200 New	37,200 $1.3 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.